Have you ever wondered if you are giving your science the best chance to reach the market, or how you can best serve patients and investors?
The first episode of the Better Biotech Growth webinar series ensures you make the best decisions for your asset. From identifying the right indications to aligning development with pricing and access dynamics, this session will explore how early, evidence-based choices can maximize long-term success.
This webinar will cover:
- The importance of early indication selection for assets that have the potential to be developed in multiple spaces
- How early pricing and market access considerations can shape development choices and maximize long-term value
- Potential pitfalls in decision-making and how to avoid them
- Key variables to consider and why they are relevant early in development
This event is free of charge. Register now to learn how to make structured, data-driven decisions that strengthen development and ultimately capture value.
Event details:
Wednesday, September 24 | 5:00 – 6:00 p.m. CEST; 11:00 a.m. – 12:00 p.m. EDT
